Britain poised to offer Eli Lilly’s weight-loss drug to patients
If the guidance is confirmed, Mounjaro will challenge the dominance of Novo’s Wegovy in the United Kingdom.
Health Care & Insurance
Articles
New director for IU Indy bioscience institute sets precision medicine as major goal
James Lin, a biomedical researcher who has focused on new innovations for tissue engineering and regenerative medicine, will start his new job in Indianapolis on Aug. 26.
Community Health planning $335M hospital in Westfield
The 425,000-square-foot project will mark the Indianapolis-based health care system’s first hospital in Hamilton County.
In the pandemic, we were told to keep 6 feet apart. There’s no science to support that.
Congressional investigators are set Monday to press Dr. Anthony Fauci on why the CDC’s recommendation was allowed to shape so much of American life for so long, particularly given Fauci and other officials’ recent acknowledgments that there was no science behind the six-foot rule after all.
Weight-loss drug shortages lead to tracker from startup
Ro’s tracker is the latest in the frenzy surrounding weight-loss drugs made by Novo Nordisk and Indianapolis-based Eli Lilly and Co.
Planned Parenthood to ask judge to expand health exception to Indiana abortion ban
The plaintiffs say the ban’s exceptions for protecting health are written so narrowly that in practice, many doctors won’t end a pregnancy even when a woman’s condition qualifies under the statute.
Elanco to launch product that reduces dairy cattle methane emissions
Elanco has called Bovaer a potential blockbuster, meaning it could ring up annual sales of at least $100 million.
Lilly’s huge expansion plan took place at record speed to reduce bottlenecks for Mounjaro, Zepbound
The company said the site footprint will not expand, but the company will fill in the property with more buildings and equipment. Manufacturing capacity will almost triple there.
Despite surging demand for long-term care, providers struggle to find workers
A survey of hundreds of nursing home providers by the American Health Care Association found almost all have open jobs and difficulty recruiting.
Purdue, Elanco to develop shared-use facility at new innovation district in Indy
Elanco also announced a commitment to purchase an additional 12 acres to the north of its planned headquarters for future expansion and the development of the Epicenter for Animal Health.
Daily marijuana use outpaces daily drinking in United States, new study says
From 1992 to 2022, the per-capita rate of reporting daily or near-daily marijuana use increased 15-fold.
Softer federal stance on marijuana could boost legalization efforts in Indiana
Some advocates wonder if the proposed reclassification of marijuana could be the game changer that opens the floodgates for legalization in the state’s 2025 legislative session.
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs
Novartis Manufacturing LLC told a committee of the City-County Council on Monday evening that it plans to spend up to $125 million to construct and equip a 79,000-square-foot-building for radiopharmaceutical manufacturing and distribution on the city’s west side.
Butler University to start four-year nursing program in 2025
The Indiana Board of Nursing has accredited the university to accept 48 students a year, meaning the program will have nearly 200 students when it is fully enrolled across four years.
Hims debuts $199 weight-loss shots, takes aim at Lilly’s Zepbound
Hims can offer the prescription weight-loss drugs because U.S. regulators have rules that allow pharmacies to make copycat versions of drugs in shortage, a practice that’s known as “compounding.”
Indiana Hospital Association names interim president
Dye takes over for longtime leader Brian Tabor, who recently said he would be stepping down from his role with IHA. Tabor joined the association in 2008 and had been president since 2016.
Justice Department formally moves to reclassify marijuana as less dangerous drug
A proposed rule sent Thursday to the federal register recognizes medical uses of cannabis and acknowledges it has less potential for abuse than some of the most dangerous drugs.
Lilly settles with spa selling knockoff versions of its popular diabetes, weight-loss drugs
In a series of lawsuits Lilly filed in September and October in federal court, the drugmaker had accused Totality Medispa of trademark infringement, false advertising, unfair competition and unfair trade practices.
Fewer U.S., Indiana overdose deaths reported last year, but experts cautious
Prescription painkillers once drove the nation’s overdose epidemic, but they were supplanted years ago by heroin and more recently by illegal fentanyl.
Lilly girding for questions over Alzheimer’s treatment from FDA committee
The U.S. Food and Drug Administration is convening a panel of independent experts on June 10 to discuss donanemab’s safety and effectiveness, including the results in patients in a clinical trial.